Address
52 Discovery
Irvine, CA 92618
United States of America (the)
Phone
949 297 7000
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
3600
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Catherine Szyman | Chief Executive Officer & Director | 2.12M | 1967 |
| Steven J. Barker | Chairman of Scientific Advisory Board & Chief Science Officer | 139,555 | 1945 |
| Ammar Al-Ali | Chief of Engineering, Innovation & Design | 516,693 | 1963 |
| Greg Meehan | Chief Commercial Officer | 632,632 | 1964 |
| Anand Sampath | Executive Vice President of Operations | 798,210 | 1966 |
| Charles Dadswell | Executive Vice President & General Counsel | 934,031 | 1959 |
| Yongsam Lee | Executive Vice President & Chief Information Officer | 1.1M | 1965 |
| Micah Young | Executive Vice President & Chief Financial Officer | 1.38M | 1979 |
| Daniel Cantillon | Chief Medical Officer | 0 | N/A |
| Eli Kammerman | Vice President of Business Development & Investor Relations | 0 | N/A |
| Matthew Brinckman | Senior Vice President of FP&A and Investor Relations | 0 | N/A |
| Paul Hataishi | Senior Vice President & Chief Accounting Officer | 0 | 1975 |
| Tim Benner | Chief Marketing & Strategy Officer | 0 | 1968 |
| Elisabeth A. Hellmann | Chief Human Resources Officer | 0 | 1969 |
| Linnette Torres | Executive Vice President of Quality & Regulatory | 0 | N/A |
| Huimin Wang | President of Japan & Asia Pacific | 0 | 1957 |
| Tetsuro Maniwa | President of Masimo Japan | 0 | N/A |
Masimo Corporation is a global innovator, producer, and seller of advanced non-invasive patient monitoring technologies and comprehensive hospital automation systems. Its flagship Masimo Signal Extraction Technology (SET) pulse oximetry is designed to overcome the typical drawbacks of traditional pulse oximeters, offering accurate measurements even with patient movement or low blood perfusion. The sophisticated Masimo rainbow SET platform expands upon this, featuring Rainbow SET Pulse CO-Oximetry products. These devices enable the non-invasive tracking of various hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate, all derived from plethysmography. Furthermore, the platform non-invasively measures hemoglobin concentration, carboxyhemoglobin, and methemoglobin levels, monitors arterial oxygen saturation and acoustic respiration rate, and calculates oxygen content along with the oxygen reserve index. Beyond oximetry, Masimo's portfolio includes SedLine brain function monitoring, which assesses the brain's electrical activity through EEG signal detection. Their capnography and gas monitoring product line encompasses external plug-in analyzers, integrated modules, handheld devices, and specialized sampling lines. The company also offers O3 regional oximetry for assessing tissue oxygen saturation and a range of hemodynamic monitoring solutions. The Masimo Hospital Automation platform provides advanced solutions such as Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. Complementing these, Masimo supplies connectivity devices, nasal high flow ventilation, and neuromodulation solutions. Masimo distributes its offerings through a direct sales force, a network of distributors, and original equipment manufacturer (OEM) partners. Its diverse client base spans hospitals, emergency medical services, home care providers, long-term care facilities, physician offices, veterinarians, and direct consumers. Consumer and non-medical products are also available via its e-commerce website, masimopersonalhealth.com. Established in 1989, the company maintains its corporate headquarters in Irvine, California.